Xie Chencheng, Lu Huarui, Nomura Alice, Hanse Eric Allan, Forster Colleen Lynn, Parker Josh Berken, Linden Michael Andrew, Karasch Chris, Hallstrom Timothy Curtis
Department of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA.
Department of Surgery, University of Minnesota, Minneapolis, MN, 55455, USA.
Mol Cancer. 2015 Apr 24;14:93. doi: 10.1186/s12943-015-0360-y.
Rb1 is the most frequently mutated gene in the pediatric cancer retinoblastoma, and its loss causes E2F transcription factors to induce proliferation related genes. However, high E2F levels following pRB loss also induce apoptosis-promoting genes as a safeguard mechanism to suppress emergent tumors. Although p53 accumulation and apoptosis induction is believed to be a primary mechanism to eliminate cells with excess E2F activity, p53 deletion doesn't suppress RB/E2F induced apoptosis in vivo in the retina. This prompted us to test the PTEN/PI3K/AKT signaling pathway on RB/E2F apoptosis suppression in vivo, to ascertain if the PI3K pathway may provide a potential avenue for retinoblastoma therapy.
We developed a mouse model in which Rb1 and Pten were conditionally deleted from retinal progenitor cells using Chx10-Cre, whereas Rbl1 (p107) was constitutively deleted. Pathway components were also tested individually by in vivo electroporation into newborn retinas for an effect on apoptosis and tumor initiation. Mouse retinal tissues were analyzed by immunohistochemistry (IHC) for proliferation, apoptosis, and pathway activation. ShRNAs were used in vitro to assess effects on apoptosis and gene expression.
Co-deleting Pten with Rb1 and Rbl1 in mouse retinal progenitor cells (RPCs) causes fully penetrant bilateral retinoblastomas by 30 days and strongly suppresses Rb/E2F-induced apoptosis. In vivo electroporation of constitutively active (ca)-Pik3ca, ca-Akt, or dominant-negative (dn)-Foxo1 into apoptosis prone newborn murine retina with deleted Rb/p107 eliminate Rb/E2F induced apoptosis and induce retinoblastoma emergence. Retinal deletion of Pten activates p-AKT and p-FOXO1 signaling in incipient retinoblastoma. An unbiased shRNA screen focusing on Akt phosphorylation targets identified FOXOs as critical mediators of Rb/E2F induced apoptosis and expression of Bim and p73 pro-apoptotic genes.
These data indicate that we defined a key molecular trigger involving E2F/FOXO functioning to control retinal progenitor cell homeostasis and retinoblastoma tumor initiation. We anticipate that our findings could provide contextual understanding of the proliferation of other progenitor cells, considering the high frequency of co-altered signaling from RB/E2F and PTEN/PI3K/AKT pathways in a wide variety of normal and malignant settings.
Rb1是儿童癌症视网膜母细胞瘤中最常发生突变的基因,其缺失会导致E2F转录因子诱导增殖相关基因。然而,pRB缺失后E2F水平升高也会诱导促凋亡基因,作为抑制新生肿瘤的一种保护机制。尽管p53积累和凋亡诱导被认为是消除具有过量E2F活性细胞的主要机制,但p53缺失并不能在体内抑制视网膜中RB/E2F诱导的凋亡。这促使我们在体内测试PTEN/PI3K/AKT信号通路对RB/E2F凋亡抑制的作用,以确定PI3K通路是否可能为视网膜母细胞瘤治疗提供一条潜在途径。
我们构建了一种小鼠模型,利用Chx10-Cre从视网膜祖细胞中条件性删除Rb1和Pten,而Rbl1(p107)则被组成性删除。还通过体内电穿孔将通路成分单独导入新生小鼠视网膜,以检测其对凋亡和肿瘤发生的影响。通过免疫组织化学(IHC)分析小鼠视网膜组织的增殖、凋亡和通路激活情况。在体外使用短发夹RNA(shRNA)评估其对凋亡和基因表达的影响。
在小鼠视网膜祖细胞(RPCs)中同时删除Pten与Rb1和Rbl1会在30天时导致完全显性的双侧视网膜母细胞瘤,并强烈抑制Rb/E2F诱导的凋亡。将组成型激活(ca)-Pik3ca、ca-Akt或显性负性(dn)-Foxo1通过体内电穿孔导入Rb/p107缺失且易于发生凋亡的新生小鼠视网膜,可消除Rb/E2F诱导的凋亡并诱导视网膜母细胞瘤出现。视网膜中Pten的缺失会激活早期视网膜母细胞瘤中的p-AKT和p-FOXO1信号。一项针对Akt磷酸化靶点的无偏shRNA筛选确定FOXO是Rb/E2F诱导凋亡以及Bim和p73促凋亡基因表达的关键介质。
这些数据表明,我们定义了一个涉及E2F/FOXO功能的关键分子触发因素,以控制视网膜祖细胞的稳态和视网膜母细胞瘤的起始。考虑到在各种正常和恶性环境中RB/E2F和PTEN/PI3K/AKT通路信号共同改变的高频率,我们预计我们的发现可以为其他祖细胞的增殖提供背景理解。